Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.
Personal genomics seemed to be on a rocketship trajectory until the FDA sent a warning letter to 23andMe questioning marketing materials that bordered on self diagnosis.
February 3, 2014
9 Min Read
You May Also Like
